Belgium· BE-AMP-SAM133761-00
Solu-Medrol S.A.B. 40 mg
A methylprednisolone product containing methylprednisolone sodium succinate, registered in Belgium by Pfizer. The same ATC class is registered in 15 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Methylprednisolone is registered in 15 of 19 countries.
Countries holding a registration under ATC H02AB04 (methylprednisolone), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 9 of them publish a price we can compare per daily dose
Methylprednisolone · ATC H02AB04
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of methylprednisolone costs, country by country.
Normalised to the WHO defined daily dose (7.5 mg), the median price runs from $0.13 in Italy to $0.85 in Switzerland — a ×6.4 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Methylprednisolone · price per daily dose (7.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.85
- IT Italy$0.13
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Methylprednisolone Sodium Succinate
- Manufacturer
- Pfizer
- Country
- Belgium (BE)
- ATC code
- H02AB04
- ATC class
- Methylprednisolone
- Defined daily dose
- 7.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 5
- be_apb0153569
- be_apb0728576
- be_apb7729189
- be_apb4117768
- be_apb0152744
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
802 interactions on record for methylprednisolone.
Graded by severity as the source publishes them — 84 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Methylprednisolone · interactions on record
802 records
- 84 severe
- 367 moderate
- 43 minor
- 288 info
Most severe, free to view
- LonafarnibA16AX20severe
- DesirudinB01AE01severe
- ConivaptanC03XA02severe
- Magnesium hydroxideA02AA04moderate
20 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Methylprednisolone in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomMethylprednisolone sodium succinate 40mg powder and solvent for solution for injection vialsA A H Pharmaceuticals Ltd
- FinlandSolu-MedrolOrifarm Oy
- United StatesMethylprednisolone sodium succinateDr. Reddy's Laboratories Inc
- GermanyMethylprednisolon AcisAcis Arzneimittel Gmbh
- CzechiaSOLU-MEDROLPfizer, spol. s r.o., Praha
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Solu-Medrol
- Bulgaria · Метилпреднизолон Чайкафарма
- Czechia · Solu-Medrol
- Germany · Methylprednisolon Hikma, Metypred
- Spain · Urbason
- France · Methylprednisolone Hikma
- United Kingdom (Northern Ireland) · Methylprednisolone Hikma Farmacêutica (Portugal), Methylprednisolone Pfizer
- Hungary · Metilprednizolon Teva
- Italy · Cortrium, Lisamethyle
- Poland · Meprelon
- Portugal · Metilprednisolona Hikma
- Slovakia · Metylprednizolón Hikma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bf7b8a33-e053-4b10-ad0d-776d8b2f495b GET /v1/drugs/bf7b8a33-e053-4b10-ad0d-776d8b2f495b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and solvent for solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Solu-Medrol S.A.B. 40 mg",
"name_fr": "Solu-Medrol S.A.B. 40 mg",
"name_nl": "Solu-Medrol S.A.B. 40 mg",
"amp_code": "SAM133761-00",
"strengths": [
"17.5000",
"25.0000",
"1.8000"
],
"pack_count": 3,
"substances": [
"Methylprednisolone Sodium Succinate",
"Disodium Hydrogen Phosphate",
"Lactose",
"Sodium Dihydrogen Phosphate Monohydrate",
"Sodium Hydroxide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Methylprednisolone",
"authorisation_numbers": [
"BE133761"
]
}See everything about methylprednisolone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.